ocu200
ocu200: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Ocugen, Inc. (OCGN) | Phase 1 |
Clinical Trials (1)
A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema
Frequently asked questions
Who is developing ocu200?
ocu200 is being developed by Ocugen, Inc..
How many clinical trials involve ocu200?
BioSniper tracks 1 clinical trial involving ocu200.
Get deeper analysis on ocu200
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis